A study by researchers at Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences at Tufts, and Tufts Medical Center improves our current understanding…

Not only is acupuncture as effective as drug therapy at reducing hot flashes in breast cancer patients, it has the added benefit of potentially increasing a…

1. What are BRCA1 and BRCA2?

BRCA1 and BRCA2 are human genes that belong to a class of genes known as tumor suppressors.

In normal cells, BRCA1 and BRCA2…

Although BRCA1-associated breast cancer is rare, comprising only 5% of breast cancers or fewer than 10,000 cases per year in the United States, academic interest outstrips its clinical impact;…

Women with breast cancer who take aspirin at least twice a week can more than double their chance of survival, a media report said citing researchers.

The greatest protection comes…

Young women diagnosed with breast cancer are uniquely impacted by issues often not faced by older women. Breast cancer is often detected at later stages, increasing diagnoses…

One in eight women diagnosed with breast cancer is younger than 45 when diagnosed, yet their emotional and medical concerns are different than those of women over age 45, as…

There are no scientific studies showing that lymphedema can be prevented, but there are ways to lower your risk of developing this treatment side effect. During the 10th Annual Conference for…

Lymphedema, a chronic swelling condition that can appear after breast cancer surgery, is a risk for 1.3 million breast cancer survivors. Although lymphedema can cause lifelong…

A University of Melbourne study has revealed that certain breast cancer genetic variants increase mammographic density, confirming the link between mammographic breast density and breast cancer.

Professor…

Cancer, the peer-reviewed international journal of the American Cancer Society, has published a study conducted by HealthCore, Inc. in its Jan. 1 edition, demonstrating disparities in breast cancer…

Expensive extra scans using MRI on breast cancer patients make no difference to the number of patients who have a repeat operation, scientists said on Friday, raising…

The master gene called SRC-3 (steroid receptor coactivator 3) not only enhances estrogen-dependent growth of cancer cells by activating and encouraging the transcription of a genetic message into a…

Breast cancer rates are declining, but some groups have seen a more significant decline than others, with race, ethnicity and economic background playing a part.

According to a…

Only a small number of U.S. women at high risk of breast cancer have chosen to use the drug tamoxifen to lower that risk, according to a…

Researchers with the National Cancer Institute (NCI) have found that the prevalence of tamoxifen use for the prevention of breast cancer among women without a personal history of breast…

The cancer drug Herceptin combined with chemotherapy works better than chemotherapy alone in patients with a certain type of advanced or inflammatory breast cancer, doctors said on Friday.

They said the…

Case Western Reserve University School of Medicine has been awarded six Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP) grants for innovative medical research. The…

Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been…

An abnormality in two genes can make a common class of chemotherapy drugs used to fight breast cancer less effective, U.S. researchers said on Sunday in a finding that…

Depression is a major health issue for breast cancer survivors, but new research hints that regular exercise and drinking green tea may help.

Exercising regularly and drinking green tea…

A study by researchers at Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences at Tufts, and Tufts Medical Center improves our current understanding…

A genetic mutation can significantly increases a woman’s risk of developing breast cancer and ovarian cancer. But does that mean everyone should be tested?

A new direct-to-consumer advertising campaign…

2010 marks the 10th anniversary of the only international conference dedicated to the critical issues of young breast cancer survivors and those…

Agendia, a world leader in molecular cancer diagnostics, announced that the US Food and Drug Administration (FDA) cleared its MammaPrint breast cancer recurrence test for all ages. MammaPrint is the only…